How the COVID-19 pandemic changed cellular therapy at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital.
Transfusion
; 60(9): 1905-1909, 2020 09.
Article
in English
| MEDLINE | ID: covidwho-613577
ABSTRACT
New York is at the epicenter of the coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 virus. Columbia University Irving Medical Center/NewYork-Presbyterian Hospital (CUIMC/NYPH) had to make changes to its cellular therapy operations to ensure patient, donor, and staff safety and well-being. In this article, we discuss the process changes we instituted for cellular therapy clinical care, collection, processing, and cryopreservation to cope with the rapidly evolving pandemic.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Academic Medical Centers
/
Pandemics
/
Cell- and Tissue-Based Therapy
/
SARS-CoV-2
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Adult
/
Child
/
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Transfusion
Year:
2020
Document Type:
Article
Affiliation country:
Trf.15956
Similar
MEDLINE
...
LILACS
LIS